Paclitaxcel Injection 30mg/5ml | 100mg/16.7ml | 260mg/43.4ml

Description

Paclitaxel Injection

• Product Overview
Paclitaxel Injection is a taxane-class anticancer medication used in the treatment of various solid tumors. It works by interfering with microtubule function, preventing cancer cell division and growth. Paclitaxel is administered by intravenous infusion under the supervision of an oncologist or healthcare professional.

• Available Strengths
– Paclitaxel 30 mg/5 mL Injection
– Paclitaxel 100 mg/16.7 mL Injection
– Paclitaxel 260 mg/43.4 mL Injection

• Therapeutic Category
Anticancer Agent / Taxane Chemotherapy

• Indications
Paclitaxel Injection is indicated for:
– Breast Cancer
– Ovarian Cancer
– Non-Small Cell Lung Cancer (NSCLC)
– Pancreatic Cancer (as prescribed)
– Kaposi’s Sarcoma Associated with AIDS
– Other Approved Solid Tumor Indications

• Common Side Effects
Some patients may experience:
– Hair loss (alopecia)
– Nausea and vomiting
– Fatigue
– Peripheral neuropathy (tingling or numbness)
– Low blood cell counts
– Injection site reactions

• Serious Side Effects
Seek immediate medical attention if any of the following occur:
– Severe allergic reactions (hypersensitivity reactions)
– Severe bone marrow suppression
– Serious infections
– Heart rhythm abnormalities
– Severe nerve-related symptoms

• Precautions
– Use only under oncologist supervision.
– Premedication may be required to reduce hypersensitivity reactions.
– Regular monitoring of blood counts and liver function is recommended.
– Use cautiously in patients with liver impairment or low blood cell counts.
– Store according to manufacturer recommendations and protect from light.

• Technical Information

• Active Ingredient
– Paclitaxel:
– 30 mg/5 mL
– 100 mg/16.7 mL
– 260 mg/43.4 mL

• Mechanism of Action
Paclitaxel stabilizes microtubules and prevents their normal breakdown, blocking cell division and leading to cancer cell death.

• Dosage Form
Sterile Concentrate Solution for Infusion

• Route of Administration
Intravenous (IV) Infusion

• Shelf Life
24–36 Months (depending on packaging and regulatory requirements)

• Storage Conditions
Store as per manufacturer instructions, protected from light.

• Product Specifications
Product Name:- Paclitaxel Injection
Generic Name:- Paclitaxel
Strength:- 30 mg/5 mL, 100 mg/16.7 mL, 260 mg/43.4 mL
Dosage Form:- Sterile Concentrate for Infusion
Category:- Oncology / Taxane Chemotherapy
Packaging:- Glass Vial / Customized Export Packing
Pack Size:- 1 Vial
Shelf Life:- 24–36 Months
Storage:- As per manufacturer specification
Origin:- India

• Regulatory Status & Supply Information
– Manufactured in WHO-GMP compliant facilities.
– Available for international oncology markets (subject to importing country regulations).
– Export documentation support available.
– Private Label Manufacturing available where permitted.
– Third-Party Manufacturing available.
– Customized export packaging available.
– Bulk supply available for oncology distributors, hospitals, cancer centers, and government tenders.

• Who Should Source This Product?
This product is ideal for:
– Pharmaceutical Importers
– Oncology Product Distributors
– Cancer Treatment Centers
– Hospital Procurement Companies
– Government Healthcare Programs
– Tender Suppliers
– Specialty Medicine Suppliers

• Why Source From Mediora Exports?
– Trusted Pharmaceutical Exporter from India
– WHO-GMP Manufacturing Partners
– Competitive International Pricing
– Wide Oncology Product Portfolio
– Reliable Global Supply Chain
– Flexible Packaging Options
– Complete Export Documentation Support

• Contact Details
Mediora Exports

📧 Email: info@medioraexports.com
📱 Phone/WhatsApp: +91 99047 64844